This activity is specifically designed for:
Program managers
Clinicians
Public health policy makers
Donors and implementing partners
Civil society organizations
Manufacturers
Diagnostics experts
Others interested in advancing triple elimination through expansion of hepatitis B
At the end of the webinar, learners should be knowledgeable of:
Updated WHO guidance on screening, prophylaxis, and treatment of hepatitis B relevant to prevention of vertical transmission of hepatitis B
Key implementation considerations that can help accelerate adoption of the updated guidelines
Overview of hepatitis B diagnostics and medications available in LMICs for use in ANC screening, prophylaxis, and treatment
Funding opportunities for hepatitis B interventions in MCH settings
The purpose of this webinar is to provide practical considerations for commodities and service delivery to advance triple elimination through expansion of hepatitis B.
Key considerations for implementation of hepatitis B interventions in antenatal care settings
Current landscape of hepatitis B diagnostics and medications
Global Fund support for hepatitis B testing and treatment among pregnant women
Dr Laura Broyles, The Global Health Impact Group
Philippa Easterbrook, WHO Geneva
Oriel Fernandes, Clinton Health Access Initiative
Satvinder Singh, Global Fund
Add your email to the mailing list to get the latest updates.
